Showing 121-130 of 6059 results for "".
Who's Responsible for Your Receivables?
https://practicaldermatology.com/topics/general-topics/PD0109_02-php/22889/When it comes to timely collection of payments, different staff members have important responsibilities.A Closer Look at Sunscreens: Insights, Innovations, and Inaccuracies
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-closer-look-at-sunscreens-insights-innovations-and-inaccuracies/20504/Experts weigh in on the current state of SPF and skin protection.The Inside Scoop on Cosmeceuticals: From Top to Bottom
https://practicaldermatology.com/topics/general-topics/the-inside-scoop-on-cosmeceuticals-from-top-to-bottom/20896/Top derms dish about their favorite cosmeceuticals, including options beyond wrinkle fighting.Case Report: Pityriasis Versicolor: Using the Wood's Lamp in Diagnosis; Residents of Distinction Honored
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-pityriasis-versicolor-using-the-woods-lamp-in-diagnosis-residents-of-distinction-honored/21011/Noah Worcester 2024: Dr. Gottlieb on Psoriatic Arthritis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gottlieb-psoriatic-arthritis/24594/Alice Gottlieb, MD, PhD, summarizes her lecture on the critical role of the dermatologist in preventing disability due to psoriatic arthritis at the 2024 Noah Worcester Dermatological Society meeting.DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit
https://practicaldermatology.com/topics/psoriasis/dermwiretv-incytes-opzelura-bms-patient-week-science-of-skincare-summit/20003/Incyte’s Opzelura is the first topical JAK inhibitor approved in the US. Lawrence Eichenfield, MD weighs in on the cream formulation of ruxolitinib for treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. Bristol Myers Squibb's seventh Global PScientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.Anatomy Lesson: Targeting the Underlying Cause of Wrinkles with Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anatomy-lesson-targeting-the-underlying-cause-of-wrinkles-with-injections/19778/Patients need to understand that addressing the underlying causes of wrinkles and folds such as changes in bony structures with injectables will provide a more natural result than simply chasing wrinkles and folds, says Jeanette M. Black, MD.Where There's a WLL
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/where-theres-a-wll/19711/The Woodward Laser Eyelash Lift (WLL) uses an excision laser to provide a long-term lifting of the eyelashes. Creator Julie Woodward, MD describes the technique.PD Asks: What would your staff say is the one thing you do that most aggravates them?
https://practicaldermatology.com/topics/practice-management/pd-asks-what-would-your-staff-say-is-the-one-thing-you-do-that-most-aggravates-them/19695/John E. Harris, MD, PhD explains why his frequent travel might leave his staff feeling a bit annoyed at times!